Immunogenicity assessment of monoclonal antibody products: A simulated case study correlating antibody induction with clinical outcomes
Authors:
Open Access
- 1 September 2015
- journal article
- review article
- Published by Elsevier in Biologicals
- Vol. 43 (5) , 307-317
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Immunogenicity assessment of biotherapeutic products: An overview of assays and their utilityBiologicals, 2015
- Case studies on clinical evaluation of biosimilar monoclonal antibody: Scientific considerations for regulatory approvalBiologicals, 2015
- The role of the quality assessment in the determination of overall biosimilarity: A simulated case study exerciseBiologicals, 2014
- Assessing Immunogenicity of Biosimilar Therapeutic Monoclonal Antibodies: Regulatory and Bioanalytical ConsiderationsBioanalysis, 2013
- Correlation of screening and confirmatory results in tiered immunogenicity testing by solution-phase bridging assaysJournal of Pharmaceutical and Biomedical Analysis, 2013
- WHO/KFDA joint workshop on implementing WHO guidelines on evaluating similar biotherapeutic products, Seoul, Republic of Korea 24–26 August, 2010Biologicals, 2011
- Taking immunogenicity assessment of therapeutic proteins to the next levelBiologicals, 2011
- Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology productsJournal of Immunological Methods, 2008
- Strategies and Assays for the Assessment of Unwanted ImmunogenicityJournal of Immunotoxicology, 2006
- Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology productsJournal of Immunological Methods, 2004